Neoplasm of Uncertain Malignant Potential: Clinical Trials

1 trial for Neoplasm of Uncertain Malignant Potential, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1

Follow Neoplasm of Uncertain Malignant Potential: new trials by email Literature Review of Neoplasm of Uncertain Malignant Potential trials Research Report on Neoplasm of Uncertain Malignant Potential

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
PEG-Interferon Alfa-2b in Treating Young Patients With Plexiform Neurofibroma
PEG-interferon alfa-2a - Neoplasm of Uncertain Malignant Potential, Unspecified Childhood Solid Tumor, Protocol Specific
Phase 1CompletedNational Institutes of Health Clinical Center (CC)362005-09-012012-03-29

Interventions

peginterferon alfa-2a (1)

Sponsors

National Institutes of Health Clinical Center (CC) (1)

Countries

United States (1)

Top investigators

Brigitte C. Widemann, MD (1)

Results publications

PMID 21242495